Risedronate Sodium Tablet, Film Coated
FDA Recall NDC 33342-107

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Risedronate Sodium (NDC 33342-107). A significant event, classified as Class III, was initiated on Mar 10, 2022 by Macleods Pharmaceuticals Limited. The reported reason for this action was: "FAILED CONTENT UNIFORMITY SPECIFICATIONS"

This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.

Reported Recall Events

March 2022 Class III Recall: FAILED CONTENT UNIFORMITY SPECIFICATIONS

Recall Number
Class III Terminated
Reason for Recall
FAILED CONTENT UNIFORMITY SPECIFICATIONS
Initiated
Mar 10, 2022
Reported
Apr 13, 2022
Quantity
4872 bottles

Recall Profile & Regulatory Data

Event ID
89766
Classification
Class III
Enforcement Status
Terminated
Recalling Firm
Macleods Pharma Usa Inc
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide
Termination Date
Jun 29, 2023
Product Description
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
Batch or Lot Expiration Information
Lot# : BRD2001A, Exp 5/2022
Affected Packages Involved in this Recall
33342-107-07Product
33342-107-49Product
33342-107-06Product
33342-108-07Product
33342-108-15Product
33342-108-06Product
33342-109-37Product
33342-109-50Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.